register

News & Trends - Pharmaceuticals

Cutting red tape in WA for medicinal cannabis access

Health Industry Hub | November 19, 2019 |

WA Health Minister Roger Cook announced that GPs will now be able to prescribe medicinal cannabis via TGA special access approval and that specialist prescriptions are no longer required for the majority of people seeking medicinal cannabis.

The change brings Western Australia closer into line with other Australian jurisdictions including New South Wales, Queensland and Victoria,
which do not currently require specialist support medicinal cannabis approvals from the TGA.

“Whilst the listing of medicines on the Pharmaceutical Benefits Scheme is the responsibility of the Federal Government, it is important for the Commonwealth to have a flexible system that expedites affordable access to new and emerging healthcare treatments.” said WA Health Minister Roger Cook.

Dr Sanjay Nijhawan, medical director at Cannabis Access Clinics, an SCH company commented “This is a step in the right direction for patients in Western Australia, many of whom could benefit from medicinal cannabis based treatments under the guidelines released by the TGA”.

You may also like Where credibility and trust go, clinicians follow. Download whitepaper.

Andrew Glover, General Manager at Cannabis Access Clinics added “We congratulate Minister Cook for taking steps towards a more streamlined approach for medicinal cannabis access. We expect costs and timelines to come down as a result and more patients in WA will be able try this treatment option as a result”.

Cannabis Access Clinics, which offers bulk billing consults for eligible patients in WA expects patient numbers  to rise significantly with this announcement.

From November 2016 until August 2019 there were 876 approvals to prescribe medicinal cannabis in Western Australia.

Medicinal cannabis products are not approved for use by the Therapeutic Goods Administration or funded by the federally controlled Pharmaceutical Benefit Scheme. They remain classified as controlled drugs throughout Australia.

Register FREE to receive the latest news and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


Digital & Innovation

Cybersecurity tops investment priorities for ANZ companies

Cybersecurity tops investment priorities for ANZ companies

Health Industry Hub | September 17, 2024 |

Digital & Innovation: Cybersecurity remains the top technology investment for Australian and New Zealand (ANZ) companies, with a striking 88% […]

More


News & Trends - Pharmaceuticals

Novo Nordisk and Lilly's GLP-1 agonists show promise in type 1 diabetes

Novo Nordisk and Lilly’s GLP-1 agonists show promise in type 1 diabetes

Health Industry Hub | September 17, 2024 |

Pharma News: GLP-1 receptor agonists lead to significant weight loss and improve blood sugar control in individuals with type 1 […]

More


News & Trends - MedTech & Diagnostics

Health Department’s proposed reporting rules face industry pushback over costs and confidentiality

Health Department’s proposed reporting rules face industry pushback over costs and confidentiality

Health Industry Hub | September 17, 2024 |

MedTech News: The Department of Health has unveiled stakeholder feedback on the reporting requirements for the Prescribed List (PL), sparking […]

More


News & Trends - MedTech & Diagnostics

Threat to innovation: Health Department’s PL reforms spark industry backlash

Threat to innovation: Health Department’s PL reforms spark industry backlash

Health Industry Hub | September 17, 2024 |

MedTech News: The Department of Health has unveiled stakeholder feedback on the alignment of charges for supplying medical devices with […]

More


This content is copyright protected. Please subscribe to gain access.